Commission Implementing Regulation (EU) 2023/997 of 23 May 2023 amending Implementing Regulation (EU) 2021/17 establishing a list of variations not requiring assessment in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (Text with EEA relevance)
recital 2recital 2
In vigore · versione del 13 giu 2023
(2) The European Medicines Agency (‘the Agency’) and the Coordination Group on Veterinary Medicinal Products (‘CMDv’) advised the Commission, on 20 December 2022, to amend points B.12 and B.24 of the Annex to Implementing Regulation (EU) 2021/17 to reflect new developments. Both the Agency and the CMDv received requests for classification of three changes to the terms of a marketing authorisation not listed in the Annex to Implementing Regulation (EU) 2021/17 that had not arisen before as variations not requiring assessment. These changes concern production equipment or processes related to production equipment, and changes in relation to the manufacturer responsible for batch release.